Search clinical trials for: Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition

Total 482066 results

Montefiore Medical Center

Completed

Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines

Migraine

United States
GlaxoSmithKline

Completed

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Migraine, Without Aura

United States
University of Alberta
Canadian Institutes of Health Research (CIHR)

Completed

Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department (EDMigraine-4)

Migraine Without Aura | Migraine With Aura | Probable Migraine

Canada
University of Florence
Azienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaborators

Recruiting

Effectiveness and Tolerability of Eptinezumab (TACHIS)

Migraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura

Italy
Chinese Academy of Medical Sciences, Fuwai Hospital

Not yet recruiting

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine (BioMetal)

Migraine | Migraine Headache | PFO - Patent Foramen Ovale | Migraine Headache, With or Without Aura

China
University of Florence
Azienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaborators

Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER) (GAINER)

Migraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura

Italy
Children's Hospital Medical Center, Cincinnati
Patient-Centered Outcomes Research Institute

Recruiting

Responding With Evidence and Access for Childhood Headaches

Migraine | Migraine Disorders | Headache | Headache Disorders | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Headache, Migraine

United States
Messoud Ashina, MD

Recruiting

Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine (ATOM)

Migraine Without Aura | Migraine With Aura

Denmark
Danish Headache Center

Recruiting

Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (ATOM)

Migraine Without Aura | Migraine With Aura

Denmark
Danish Headache Center

Recruiting

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM) (ILIM)

Headache | Migraine Without Aura

Denmark
The Third Affiliated hospital of Zhejiang Chinese...

Recruiting

A Randomized Controlled Trial of Acupuncture in Treating Migraine

Migraine Without Aura

China
Organon and Co

Completed

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

Acute Migraine
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Acute Myeloid Leukemia

United States, Canada, Puerto Rico, Australia
Organon and Co

Completed

A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)

Acute Migraine With or Without Aura in Adolescents
Allodynic Therapeutics, Inc

Completed

The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

Migraine With or Without Aura

United States
Tonix Pharmaceuticals, Inc.
Premier

Completed

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine (PREVENTION)

Chronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura Migraine

United States
Allodynic Therapeutics, Inc

Completed

An Acute Migraine Factorial Study (ANODYNE-1)

Migraine With or Without Aura

United States
Satsuma Pharmaceuticals, Inc.

Completed

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (SUMMIT)

Migraine | Migraine Without Aura | Migraine With Aura

United States
Currax Pharmaceuticals

Terminated

Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

Acute Migraine With or Without Aura

United States
Satsuma Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine (ASCEND)

Migraine | Migraine Without Aura | Migraine With Aura

United States
Satsuma Pharmaceuticals, Inc.

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (EMERGE)

Migraine | Migraine Without Aura | Migraine With Aura

United States
Pfizer

Completed

Safety and Efficacy in Adult Subjects With Acute Migraines

Migraine, With or Without Aura

United States
Pfizer

Completed

Open Label Safety Study in Acute Treatment of Migraine

Migraine, With or Without Aura

United States
Pfizer

Completed

Safety and Efficacy Study in Adult Subjects With Acute Migraines

Migraine, With or Without Aura

United States
Pfizer

Completed

Trial in Adult Subjects With Acute Migraines

Migraine, With or Without Aura

United States
Danish Headache Center

Completed

CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load

Migraine Without Aura
Satsuma Pharmaceuticals, Inc.

Completed

A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Migraine | Migraine Without Aura | Migraine With Aura

United States
Mayo Clinic

Completed

Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block

Migraine Without Aura | Cervicogenic Headache | Occipital Neuralgia

United States
Allodynic Therapeutics, LLC

Completed

Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine (ANODYNE-1)

Migraine With or Without Aura

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

Migraine With or Without Aura

Finland, Denmark, Netherlands, Norway, Sweden
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Migraine Without Aura | Migraine With Aura

Spain, France, Italy, Netherlands, Turkey, Belgium, Hungary, Czechia, Denmark, Germany, Greece, Norway, Portugal, Sweden
Danish Headache Center
Novartis Pharmaceuticals

Unknown

The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

Migraine | Migraine Without Aura | Migraine With Aura

Denmark
Eli Lilly and Company

Completed

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Migraine

Puerto Rico, United States, Hungary, Belgium, France, Canada
Leiden University Medical Center
European Commission; Netherlands Organisation for Scientific Research

Completed

1H Magnetic Resonance Spectroscopy in Migraine Patients

Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Migraine Disorders | Headache Disorders, Primary | Headache Disorders | Migraine Without Aura
Satsuma Pharmaceuticals, Inc.

Completed

A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Migraine | Migraine Without Aura | Migraine With Aura

United States
Charleston Laboratories, Inc

Completed

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Pain | Nausea | Vomiting | Migraine | Aura

United States
Eli Lilly and Company
CoLucid Pharmaceuticals

Completed

Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine (SPARTAN)

Migraine With or Without Aura

United States
Allergan

Completed

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Migraine, With or Without Aura

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (ACHIEVE II)

Migraine, With or Without Aura

United States
Danish Headache Center

Unknown

Pharmacologically Triggered Migraine Without Aura and Neuroimaging

Migraine With Aura

Denmark
Danish Headache Center

Completed

PACAP27 Headache Properties in Migraine Without Aura Patients

Migraine Without Aura

Denmark
Allergan

Completed

Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine (ACHIEVE I)

Migraine, With or Without Aura

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Migraine, With or Without Aura

United States
Merck Sharp & Dohme LLC

Completed

A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

Migraine
Merck Sharp & Dohme LLC

Completed

Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)

Migraine
Eli Lilly and Company

Terminated

A Study in Migraine Prevention

Migraine Headache

United States, Puerto Rico
Dr. Reddy's Laboratories Limited

Completed

DFN-11 Injection in Episodic Migraine With or Without Aura (RESTOR)

Episodic Migraine

United States

Search clinical trials for: Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations